Patients with mitral and tricuspid valve regurgitation, a condition sometimes called "leaky heart valves," appeared to do better after two
Study finds benefits, drawbacks to two-step surgical approach for mitral and tricuspid valve regurgitation
Home »
Breakthrough in keyhole heart valve replacement
Cardiovascular disease remains the number one cause of death worldwide. Aortic stenosis—the narrowing of the valve that controls blood flow
Unmarried adults with heart disease living in rural areas face more hopelessness, increased risk of death
Living in a rural setting and being unmarried were each linked to higher rates of hopelessness among people with heart
New strategy combining heart failure with depression treatment improves patients' clinical outcomes
A telephone-delivered nursing care strategy that combined heart failure care management with depression treatment improved patients' clinical outcomes, discovered clinicians
Periodontitis associated with increased risk of cardiovascular disease
Gum disease is associated with an increased risk of cardiovascular disease: the more severe the periodontitis, the higher the risk.
Systematic review: Efficacy and renal tolerability of ultrafiltration in acute decompensated heart failure
In a new publication from Cardiovascular Innovations and Applications, Yajie Liu and Xin Yuan from the Second Affiliated Hospital of
Heart patients need more help to lose weight
Weight loss is given insufficient priority in the management of heart patients despite the benefits, according to a study published
Understanding Heart Rate Variability Can Help You Avoid Overtraining
This is Your Quick Training Tip, a chance to learn how to work smarter in just a few moments so
Study examines heart and kidney outcomes of adults with nephrotic syndrome
A form of kidney disease called primary nephrotic syndrome is characterized by high urinary excretion of protein, low protein in
Sotagliflozin reduces adverse cardiovascular events across patients with diabetes, heart failure
Patients with both diabetes and heart failure who were treated with sotagliflozin, a novel investigational drug for diabetes, for a